Under the terms of the agreement, Just-Evotec will develop a commercial manufacturing process for Alpine’s ALPN-303 using its data-driven technology platform, J.DESIGN with the commercial development activities to be performed at its J.POD biomanufacturing facility
The extension of the partnership was based on the 2020 collaboration under which Just-Evotech provided drug substance materials through J.DESIGN for the P-I & II studies of ALPN-303
J.DESIGN is a highly automated biologics technology platform integrated with AI, ML intensified & continuous bioprocesses designed for flexible & efficient biologics development whereas ALPN-303 is a dual B cell cytokine (BAFF/APRIL) antagonist that treats inflammatory & autoimmune diseases incl. SLE
Ref: Businesswire | Image: Evotec
